Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase I data support safety and preliminary activity of MLTA3698A in active RA

Nov. 18, 2010

PET tracer [11C]-NS-14492 can visualize in vivo occupancy of nicotinic acetylcholine alpha7 receptor

Nov. 18, 2010

BSAM-2/Alhydrogel/CPG-7909 vaccine enters clinical evaluation in malaria-naive adults

Nov. 18, 2010

SUN-13837 accelerates functional recovery in rat models of spinal cord injury and stroke

Nov. 17, 2010

Preclinical and first-in-human data reported on antimalarial OZ-439

Nov. 17, 2010

EMA orphan drug status for SBC-102 in LAL deficiency / News in Context

Nov. 17, 2010

Preclinical studies evaluate Cz-007, Cz-008 and Cz-009 for treatment of Chagas' disease

Nov. 17, 2010

First oral anaphylatoxin C5a receptor antagonist CCX-168 is safe in phase I trial

Nov. 17, 2010

Abbott describes analgesic effects of A-1048400

Nov. 16, 2010

Suven Life Sciences presents SUVN-F90101 and SUVN-F91201

Nov. 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...